Mitchell Nagao
Senior Vice President - Medical Affairs
Professional Overview
Mitchell Nagao is a seasoned pharmaceutical executive with over 15 years of experience driving medical affairs strategy and leading cross-functional teams. As the Senior Vice President of Medical Affairs at Soleno Therapeutics, he is responsible for shaping the company's medical strategy, overseeing clinical programs, and fostering collaborations with key opinion leaders. Mitchell's expertise spans the rare disease and specialty pharmaceutical sectors, with a strong track record of translating medical insights into impactful commercial and clinical initiatives.
Experience Summary
Current Role
As the Senior Vice President of Medical Affairs at Soleno Therapeutics, Mitchell leads the company's medical strategy, clinical development, and medical information functions. He works closely with the executive team to align medical activities with Soleno's overall business objectives and ensure the efficient execution of clinical studies. Under Mitchell's guidance, the medical affairs team has successfully launched several educational programs and established valuable partnerships with patient advocacy groups, contributing to the company's growth and brand recognition within the rare disease community.
Career Progression
Prior to joining Soleno Therapeutics, Mitchell held various leadership roles in medical affairs and market access at Myovant Sciences, Prothena Corporation, and Actelion (now part of Janssen Pharmaceutical). He has a proven track record of driving medical strategy, managing cross-functional collaborations, and delivering impactful medical communications. Throughout his career, Mitchell has contributed to the successful development and commercialization of several specialty pharmaceutical products, demonstrating his ability to effectively bridge the gap between clinical research and real-world patient needs.
Academic Background
Mitchell holds a Doctor of Pharmacy (PharmD) degree from the University of California, San Francisco, and a Master of Business Administration (MBA) from the University of Southern California. His academic achievements and specialized training have equipped him with a unique combination of medical expertise and business acumen, allowing him to excel in the dynamic pharmaceutical industry.
Areas of Expertise
- Medical affairs strategy development and implementation
- Cross-functional team leadership and collaboration
- Clinical study design, oversight, and medical information dissemination
- Stakeholder engagement and partnership building with key opinion leaders, patient advocacy groups, and health authorities
- Market access and reimbursement strategy
- Rare disease and specialty pharmaceutical market dynamics
Professional Impact
During his tenure at Myovant Sciences, Mitchell played a pivotal role in shaping the company's medical affairs strategy and driving the successful launch of its lead product, Orgovyx, for the treatment of advanced prostate cancer. His efforts resulted in the rapid adoption of the drug among healthcare providers and the establishment of comprehensive patient support programs. At Soleno Therapeutics, Mitchell has been instrumental in advancing the company's clinical pipeline and fostering strong relationships with the rare disease community, positioning the organization for continued growth and impact.
Conclusion
With his extensive experience, proven leadership skills, and deep industry knowledge, Mitchell Nagao is a strategic and well-respected medical affairs executive. In his current role at Soleno Therapeutics, he is poised to further the company's mission of developing innovative treatments for rare and complex medical conditions, ultimately improving the lives of patients and their families.
